These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 8147888

  • 1. Inhibition of matrix metalloproteinases by peptidyl hydroxamic acids.
    Odake S, Morita Y, Morikawa T, Yoshida N, Hori H, Nagai Y.
    Biochem Biophys Res Commun; 1994 Mar 30; 199(3):1442-6. PubMed ID: 8147888
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of human stromelysin by peptides based on the N-terminal domain of tissue inhibitor of metalloproteinases-1.
    Hanglow AC, Lugo A, Walsky R, Visnick M, Coffey JW, Fotouhi N.
    Biochem Biophys Res Commun; 1994 Dec 15; 205(2):1156-63. PubMed ID: 7802645
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT, Sugiura Y, Laug WE, Sun B, Garcia A, DeClerck YA.
    J Cell Physiol; 1996 May 15; 167(2):333-40. PubMed ID: 8613475
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases.
    Szardenings AK, Harris D, Lam S, Shi L, Tien D, Wang Y, Patel DV, Navre M, Campbell DA.
    J Med Chem; 1998 Jun 18; 41(13):2194-200. PubMed ID: 9632351
    [Abstract] [Full Text] [Related]

  • 11. Matrix metalloproteinase inhibitors: a structure-activity study.
    Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE.
    J Med Chem; 1998 Jan 15; 41(2):199-223. PubMed ID: 9457244
    [Abstract] [Full Text] [Related]

  • 12. A Mr 21,000 inhibitor of matrix metalloproteinases from human fibroblasts.
    Moore WG, Birkedal-Hansen B, Pierson M, Birkedal-Hansen H.
    Matrix Suppl; 1992 Jan 15; 1():319-20. PubMed ID: 1480050
    [No Abstract] [Full Text] [Related]

  • 13. Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.
    Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V.
    J Med Chem; 1999 Jul 15; 42(14):2610-20. PubMed ID: 10411481
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of human skin fibroblast collagenase by phosphorus-containing peptides.
    Galardy RE, Grobelny D, Kortylewicz ZP, Poncz L.
    Matrix Suppl; 1992 Jul 15; 1():259-62. PubMed ID: 1480035
    [Abstract] [Full Text] [Related]

  • 15. Matrix metalloproteinase inhibitor BB-3103 unlike the serine proteinase inhibitor aprotinin abrogates epidermal healing of human skin wounds ex vivo.
    Mirastschijski U, Impola U, Karsdal MA, Saarialho-Kere U, Agren MS.
    J Invest Dermatol; 2002 Jan 15; 118(1):55-64. PubMed ID: 11851876
    [Abstract] [Full Text] [Related]

  • 16. Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases.
    Krumme D, Wenzel H, Tschesche H.
    FEBS Lett; 1998 Oct 02; 436(2):209-12. PubMed ID: 9781680
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.
    Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK.
    J Med Chem; 1997 Mar 14; 40(6):1026-40. PubMed ID: 9083493
    [Abstract] [Full Text] [Related]

  • 18. Comparison of native matrix metalloproteinases and their recombinant catalytic domains using a novel radiometric assay.
    Brownell J, Earley W, Kunec E, Morgan BA, Olyslager B, Wahl RC, Houck DR.
    Arch Biochem Biophys; 1994 Oct 14; 314(1):120-5. PubMed ID: 7944383
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of matrix metalloproteinase inhibitors against epidermal basement membrane damage: skin equivalents partially mimic photoageing process.
    Amano S, Ogura Y, Akutsu N, Matsunaga Y, Kadoya K, Adachi E, Nishiyama T.
    Br J Dermatol; 2005 Dec 14; 153 Suppl 2():37-46. PubMed ID: 16280020
    [Abstract] [Full Text] [Related]

  • 20. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM.
    Cancer Res; 2001 May 01; 61(9):3610-8. PubMed ID: 11325829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.